Corient Capital Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $923K | Buy |
|
|||||
|
2022
Q2 | $770K | Sell |
|
|||||
|
2022
Q1 | $2.46M | Sell |
|
|||||
|
2021
Q4 | $2.28M | Sell |
|
|||||
|
2021
Q3 | $2.8M | Buy |
|
|||||
|
2021
Q2 | $2.58M | Sell |
|
|||||
|
2021
Q1 | $2.14M | Sell |
|
|||||
|
2020
Q4 | $3.17M | Buy |
|
|||||
|
2020
Q3 | $3.12M | Sell |
|
|||||
|
2020
Q2 | $3.13M | Buy |
|
|||||
|
2020
Q1 | $2.41M | Buy |
|
|||||
|
2019
Q4 | $2.6M | Buy |
|
|||||
|
2019
Q3 | $2.29M | Buy |
|
|||||
|
2019
Q2 | $1.84M | Buy |
|
|||||
|
2019
Q1 | $1.71M | Sell |
|
|||||
|
2018
Q4 | $1.74M | Sell |
|
|||||
|
2018
Q3 | $3.44M | Hold |
|
|||||
|
2018
Q2 | $3.05M | Sell |
|
|||||
|
2018
Q1 | $4.78M | Sell |
|
|||||
|
2017
Q4 | $5.46M | Buy |
|
|||||
|
2017
Q3 | $5.12M | Sell |
|
|||||
|
2017
Q2 | $5.64M | Sell |
|
|||||
|
2017
Q1 | $5.38M | Buy |
|
|||||
|
2016
Q4 | $596K | Sell |
|
|||||
|
2016
Q3 | $4.38M | Buy |
|